Back to Trades
Other4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$63.8K
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Ragosa Mark
- Role
- Insider
Filing Details
- Filing Date
- Apr 8, 2026
- Transaction Date
- Apr 7, 2026
- Accession Number
- 0001835458-26-000010
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 7, 2026 | Class A Ordinary Share | 2,694 | — | Exercise | — |
| Apr 7, 2026 | Class A Ordinary Share | 1,303 | $48.94 | Tax Withholding | $63.8K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 7, 2026 | Derivative | 2,694 | — | Exercise | — |
Footnotes
- (F1)Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
- (F2)The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022.